Keratoprosthesis in congenital hereditary endothelial dystrophy after multiple failed grafts.
Congenital hereditary endothelial dystrophy (CHED) has historically been managed with penetrating keratoplasty (PK), with moderate success, and, more recently, with Descemet's stripping endothelial keratoplasty (DSEK). The possibility of repeated graft failures with CHED, however, makes alternative surgical procedures desirable. To our knowledge, this is the first reported use of a keratoprosthesis for management of CHED in a patient with multiple graft failures. The patient has been successfully followed for 5 years, has 20/30 vision, and no glaucoma.
Massachusetts Eye and Ear Infirmary and Department of Ophthalmology, Harvard Medical School.
Ramez I
RI
Haddadin
Claes H
CH
Dohlman